Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Term Topical Tetracaine for Corneal Abrasions
NCT04187417Completed
- Sponsor
- INTEGRIS Southwest Medical Center
- Start
- Jan 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of tetracaine in corneal abrasion (2 arms), sponsored by INTEGRIS Southwest Medical Center. Primary endpoint: Overall Visual Analog Scale score at 48 hours. Started Jan 2015; status: completed.
02
Drugs
tetracaine
03
Conditions
corneal abrasion
Beyond the preview
Go deeper on NCT04187417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187417.